.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AB09_Lonazolac.Lonazolac .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AB09_Lonazolac.Lonazolac| name: | Lonazolac | |
| ATC code: | M01AB09 | route: | oral |
| compartments: | 1 | |
| dosage: | 100 | mg |
| volume of distribution: | 15 | L |
| clearance: | 1.0 | L/h |
| other parameters in model implementation | ||
Lonazolac is a non-steroidal anti-inflammatory drug (NSAID) of the anthranilic acid derivative class. It was used mainly for its analgesic and anti-inflammatory effects in conditions such as rheumatoid arthritis and other musculoskeletal disorders. Lonazolac is not widely approved or marketed today in most countries; its clinical use has essentially been discontinued.
Estimated pharmacokinetic parameters for adult humans based on class characteristics due to lack of direct published data.